B. Iorgulescu

Programmed death receptor ligand one expression may independently predict survival in non-small cell lung carcinoma brain metastases patients receiving immunotherapy.

Timothy R. Smith, R. Mekary, J. Verhoeff, 2020, International journal of radiation oncology, biology, physics.

256 The TIGIT/CD226/CD155 axis and the effects of combining PD-1/PD-L1 blockade with TIGIT-targeting antibody therapy in syngeneic murine glioblastoma models

G. Freeman, P. Gokhale, A. Anderson, 2021, Journal for ImmunoTherapy of Cancer.

76 Spatial mapping of T cell receptors and transcriptomes in renal cell carcinoma following immune checkpoint inhibitor therapy

Shuqiang Li, K. Livak, Evan Murray, 2021, Journal for ImmunoTherapy of Cancer.

BIOM-44. GENOMIC PREDICTORS OF ADVERSE EVENTS IN NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA

Raymond Y Huang, R. Beroukhim, P. Wen, 2020 .